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Background: Laparoscopic distal pancreatectomy was introduced 15 years ago, but it is still not widely
used. The aim of the study was to compare the postoperative complications and length of stay between
open and laparoscopic distal pancreatectomy.
Materials and methods: A search of our institutional pancreas database was performed. All consecutive
distal pancreatectomy patients from 2000 to 2015 were identiﬁed. Demographics, peri- and post-
operative outcomes were reviewed. Postoperative complications were graded using Clavien classiﬁca-
tion. Standard statistical analyses were performed.
Results: One hundred and ﬁve patients underwent distal pancreatectomy (45 women, 60 men, median
age of 63 years). Seventy-nine cases were performed open and 26 by laparoscopy (conversion rate from
laparoscopy to laparotomy: 7/26). Characteristics of both groups were similar. The tumor proportion was
similar in both groups (56/79 and 23/26, p ¼ 0.114). Overall complication rate was 41/79 (52%) in the
open group and 9/26 (36%) in the laparoscopy group (p ¼ 0.175). Two patients died during hospital stay
in the open group compared to 0 in the laparoscopy group (p ¼ 1). The ﬁstula rates were comparable (17/
79 and 5/26, p ¼ 1). Median length of stay was shorter for the laparoscopy group (8 vs. 12 days,
p < 0.001), as well as the median intermediate care stay (1 vs. 3 days, p ¼ 0.004).
Conclusion: Short-term outcomes after open and laparoscopic distal pancreatectomy regarding post-
operative complications and mortality were similar, but length of stay was signiﬁcantly shorter for the
laparoscopic approach. Hence, laparoscopic distal pancreatectomy should be offered to all suitable
patients.
© 2016 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pancreas surgery is mostly performed for oncologic reasons, and
despite signiﬁcant technical advances during recent decades, mostSurgery, University Hospital
d.
es).
ier Ltd on behalf of IJS Publishingsurgeons still prefer open surgery as the operative procedures are
complex. Nevertheless, minimally invasive surgery has been
increasingly adopted, in particular for distal pancreatectomy (DP)
as in majority of cases only a resection is performed compared to
more complex pancreatic head resection where technically
demanding reconstructions are needed [1]. The initial imple-
mentation of laparoscopic DP was rather reluctant, but increased
since 2000 [2]. This might be explained by the need for both
thorough skills in minimally invasive techniques and in pancreasGroup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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centers that have been recently developed due to the centralization
of pancreas surgery in many countries.
Preliminary studies have shown that laparoscopy for DP was
feasible and safe [2,3], whereby a learning curve of up to 15 cases is
necessary [4e6]. More recently, several studies reported favorable
short-term outcomes like shorter operative times, less post-
operative complications, and decreased length of stay (LoS) [7e9].
A major concern for laparoscopic DP was to maintain oncologic
standards for the resection of adenocarcinomas of the body and tail
of the pancreas [10,11]. The current evidence comparing post-
operative outcomes of open to laparoscopic DP for pancreatic
adenocarcinoma is growing, but is still scarce until now [12].
The aim of the present study was to compare a single-center
experience of laparoscopic DP to open surgery with a special
emphasis on postoperative complications and LoS.
2. Materials and methods
2.1. Patients
The prospective pancreas database of the Department of
Visceral Surgery of the University Hospital of Lausanne (CHUV,
Switzerland) was searched for DP cases. All consecutive patients
from 2000 to 2015 who underwent DP were potentially eligible to
be included in the study. Patient demographics, perioperative data,
and postoperative outcomes were retrieved.
2.2. Perioperative outcomes
Intraoperative blood loss was measured at the end of the
operation by the surgeon and the anesthesiologist based on the
soaked gauze weight and the aspirated ﬂuids. Postoperative com-
plications weremeasured using the Clavien classiﬁcation [13]. They
were separated into minor (IeII) and major complications (IIIeIV).
Grade V was deﬁned as death during hospital stay or during the 60
days after the operation. LoS was calculated from operation day to
discharge date. Pancreatic ﬁstulas and postoperative hemorrhages
were deﬁned using the International Study Group of Pancreatic
Surgery (ISGPS) criteria [14,15].
2.3. Operative techniques and postoperative management
Open DP was performed using subcostal incision or midline
laparotomy. No somatostatin analogues were given prophylacti-
cally. After opening the lesser sac, the pancreas was freed all around
beginning laterally then progressing toward the pancreas neck (left
to right approach). The spleen and its vessels were preserved if
possible in patients with benign disease; otherwise the spleen was
resected en bloc with the pancreatic tail and lymph nodes. The
pancreas was transected using a linear stapler or by energy device
upon the individual surgeon's choice. In all cases, the pancreatic
stump was closed with a running suture, while targeted suture
closure of the pancreatic duct was also upon the individual sur-
geon's choice. One drainwas left in place near the pancreatic stump
at the end of the operation. This drain was removed on post-
operative day 3 if amylase in the drain ﬂuid was not 3 times higher
than serum amylase level. Epidural anesthesia was usually used.
For laparoscopic DP 4 trocars were used (one camera and three
working ports) with the patient in supine position. The camerawas
placed in the peri-umbilical trocar. The same steps as open surgery
were undertaken, except that pancreas mobilization was per-
formed from right to left (medial to lateral). The pancreas was
sectioned using an Endo-GIA© stapler or an energy device upon the
individual surgeon's choice. The stump was closed with a runningsuture. Closure of the pancreatic duct depended on the individual
surgeon's choice. A closed-suction drain was also left near the
pancreas resection side.
The choice of performing open or laparoscopic surgery was
decided by the surgeon in charge of the patient. Decisionwas based
on the body-mass index (BMI), previous abdominal surgery, or
tumor size.
Since 2012, enhanced recovery after surgery (ERAS) pathways
have been implemented for DP. They are particularly focused on
early mobilization and rapid postoperative nutrition [16].
2.4. Statistical analysis
Continuous variables were compared using a Mann-Whitney U
test or a student t-test depending on the normality of the distri-
bution and the homogeneity of the variances. Discrete variables
were compared using a Chi-square test. Survivals were calculated
using Kaplan-Meier method, and comparisons were made using
the log-rank test. Graphpad Prism for Mac OS X was used for the
statistical analyses.
This study has been approved by the local ethical committee of
the University of Lausanne Hospital. The study was performed in
accordance with the Helsinki Declaration as revised in 2013.
3. Results
3.1. Patient characteristics and operative indications
During the study period, 105 patients underwent DP, 45 women
and 60 men with a median age of 63 years (IQR 49e71 years).
Median BMI was 24.5 kg/m2 (IQR 21.1-27.5 kg/m2). A splenectomy
was added to the DP in 86 patients (82%). Indications for DP were
malignancies (64), benign tumors (15), pseudocysts (9), chronic
pancreatitis (8), and other benign diseases (9).
3.2. Open vs. laparoscopic DP
Open surgery was performed in 79 cases (75%) and laparoscopy
in 26 cases (25%). Laparoscopy was performed more frequently in
the recent years (2000e2009: 9 cases, 2010e2015: 17 cases). In the
laparoscopy group, 7 cases (27%) were converted to laparotomy due
to adhesions (4x), lesion of the splenic vein (2x), and tumoral
inﬁltration of the splenic vessels close to the celiac trunk (1x).
Characteristics of both groups are presented in Table 1. Splenec-
tomy was associated to the DP in 65 patients in the open group, 52
for oncologic reasons and 13 for technical reasons (5x resection of
splenic vessels, 3x due to hilar anatomical position of the pseudo-
cyst, 2x due to portal hypertension, 2x due to splenic vein/spleen
lesions, and 1x due to splenic vein thrombosis) and in 21 patients
(18x for oncologic reasons, 2x due to resection of splenic vessels,
and 1x due to portal hypertension and splenic vein thrombosis) in
the laparoscopy group (p ¼ 1).
Table 2 summarizes the ﬁnal diagnoses in both groups. Median
operative times were similar in both groups (225 vs. 213 min,
p ¼ 0.382). For the operations with splenectomy (n ¼ 86), median
operative time was 237 min in the open group and 244 min in the
laparoscopy group (p ¼ 0.436), whereas for DP without splenic
resection (n ¼ 19) the median operative times were 213.5 min and
213 min (p ¼ 1). Median intraoperative blood loss was 400 ml (IQR
200e900 ml) in the open group and 300 ml (IQR 75e750 ml,
p¼ 0.557) in the laparoscopy group. Blood transfusionwas required
in 21 patients (19 in the open group, 2 in the laparoscopy group,
p ¼ 0.125).
Overall complication ratewas 40/79 (51%) in the open group and
9/26 (36%) in the laparoscopy group (p ¼ 0.179), respectively. No
Table 1
Patient characteristics (medians with interquartile range and numbers with percentage).
Distal pancreatectomy Open N ¼ 79 Laparoscopy N ¼ 26 P-value
Median age, years 63 (49e71) 64 (50e73) 0.418
Median BMIa, kg/m2 23.9 (20.7e27.1) 25.5 (22.8e28.4) 0.059
Gender (men/women) 45/34 16/10 0.819
ASAb score 1/2/3 9/52/18 2/18/6 0.291
DP alone/DP þ splenectomy 13/66 5/21 0.768
Diabetes mellitus 11 (14%) 5 (19%) 0.563
Active smokers 25 (33%) 8 (31%) 1
Previous abdominal operations 6 (8%) 1 (4%) 0.678
a BMI: body-mass index.
b ASA: American Society of Anesthesiologists.
Table 2
Histopathological diagnoses.
Distal pancreatectomy Open N ¼ 79 Laparoscopy N ¼ 26 P-value
Ductal adenocarcinoma 22 (28%) 10 (40%) 0.333
Neuro-endocrine tumor 11 (14%) 7 (27%) 0.142
Mucinous cystadenoma 5 (6%) 1 (4%) 1
Serous cystadenoma 3 (5%) 1 (4%) 1
Cystadenocarcinoma 2 (3%) 0 1
IPMNa 2 (3%) 2 (7%) 0.256
Other tumorsb 11 (14%) 2 (7%) 0.511
Pseudocyst 9 (11%) 0 0.108
Chronic pancreatitis 6 (7%) 2 (7%) 1
Normal pancreatic tissue 6 (7%) 1 (4%) 0.678
Polycystosis 1 (1%) 0 1
Ectopic spleen 1 (1%) 0 1
a Intraductal papillary mucinous neoplasm.
b Other tumors included: sarcomas (4 in the open group), metastases (2 in the
open group, 1 in the laparoscopy group), gastric adenocarcinomas (2 in the open
group), undifferentiated carcinoma (1 in the laparoscopy group), solid pseudopa-
pillary tumor (1 in the open group), adenosquamous carcinoma (1 in the open
group), and adrenal carcinoma (1 in the open group).
Table 3
Postoperative outcomes (medians with interquartile range and numbers with
percentage).
Distal pancreatectomy Open N ¼ 79 Laparoscopy N ¼ 26 P-value
Overall complication 40 (51%) 9 (35%) 0.179
Minor (IeII) 18 2 0.277
Major (IIIeIV) 22 7 0.277
Mortality (V) 2 (3%) 0 (0%) 1
Pancreatic ﬁstula 15 (19%) 5 (19%) 1
Hemorrhage 17 (22%) 2 (8%) 0.147
Median ICUa stay 0 (0e0) 0 (0e0) 0.761
Median ICb stay 3 (2e4) 1 (1e2.5) 0.004
Median length of stay 12 (8e17) 8 (7e10) <0.001
60-day readmission 12 (15%) 2 (8%) 0.509
Signiﬁcant P-values appear in bold in the table.
a ICU: intensive care unit.
b IC: intermediate care.
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complications were noted (p ¼ 0.277). Two patients died post-
operatively during the hospital stay (grade V) in the open group,
whereas no patient died in the laparoscopy group (p ¼ 1). The
ﬁstula and hemorrhage rates were similar between the two groups
(15/79 vs. 5/26, p ¼ 1 and 17/79 vs. 2/26, p ¼ 0.147). Among the
ﬁstulas, there were 12 and 4 grade A, 4 and 1 grade B, and 1 and
0 grade C in the open and laparoscopy groups, respectively. For the
hemorrhages, 14 were grade A, 1 grade B, and 2 grade C in the open
group, whereas in the laparoscopy group there was 1 grade A, 1 B,
and 1 C.
Most patients did not need intensive care unit (ICU) post-
operatively in both groups (p ¼ 0.761). Median stay in intermediate
care was 3 days (IQR 2e4) in the open group compared to 1 day
(IQR 1e2.5) in the laparoscopy group (p ¼ 0.004). Median LoS was
shorter for the laparoscopy group compared to the open group (8
vs. 12 days, p < 0.001). Sixty-day readmission rates were similar
between the two groups (12/79 and 2/26, p ¼ 0.509). Table 3
summarizes the postoperative outcomes in both groups.Table 4
TNM classiﬁcation of the resected adenocarcinomas in the open and laparoscopy
groups.
Distal pancreatectomy Open N ¼ 22 Laparoscopy N ¼ 10 P-value
Tumor stage T1/T2/T3/T4 1/2/18/1 0/3/7/0 0.399
Node stage N0/N1 8/14 3/7 1
Perineural invasion 21 10 1
Vascular invasion 15 7 1
Lymphatic invasion 13 7 0.703
Margins R0/R1/R2 15/5/2 8/2/0 0.5873.3. Long-term outcomes of patients with ductal adenocarcinoma
The main tumoral etiology was adenocarcinoma. There were 22
adenocarcinomas in the open group and 10 in the laparoscopy
group (p¼ 0.333). The tumor stages were comparable (Table 4). The
rates of complete resections (R0 resections) were similar between
the open and laparoscopy groups (15/22 vs. 8/10, p ¼ 0.681). Me-
dian numbers of harvested lymph nodes were also similar (16 vs.14
lymph nodes, p ¼ 1). Vascular invasion was observed in 15 and 7
cases (p ¼ 1). The median overall survival and 5-year survival ofopen and laparoscopic DP were 32 months and 40%, and 31 months
and 19% (p ¼ 0.478), respectively.4. Discussion
This study comparing the short-term outcomes of open and
laparoscopic DP showed that LoS was shorter after laparoscopic DP
while postoperative complications and readmission rates were
similar. Moreover, intermediate care stay was also shorter in the
laparoscopy group.
Several studies found a shorter LoS for laparoscopic DP [11,17,18].
Stauffer et al. found a median LoS diminished by 4 days for lapa-
roscopic DP performed for pancreatic adenocarcinomas [11]. They
also found less blood loss and need for intraoperative transfusion,
which was not the case in the present study. Zhang et al. in a small
case-matched study found also a diminution of the LoS (13 vs. 15.5
days) [7]. On the contrary a retrospective study by Hasselgren et al.
showed no difference in the LoS but a diminution of blood loss with
laparoscopy [19]. This study additionally found that severe com-
plications and operative times decreased with experience [19]. The
laparoscopy group had the same overall complication rate as the
open group and was therefore judged safe even in the early period
G.-R. Joliat et al. / Annals of Medicine and Surgery 13 (2017) 1e54of implementation [19]. A large national French study similarly
found a decreased LoS for laparoscopy [20]. Of note, the LoS per se is
not the best measure to compare between studies as there arewide
variations related to local habits and different health care systems.
What matters the most is the difference of LoS, if present, induced
by the laparoscopic technique. The present study also found that
the stay in the intermediate care was reduced for the laparoscopy
group; reinforcing the clinical observation that smaller abdominal
access allows earlier recovery. It is interesting to note that a trend
for a median lower BMI was found in the open surgery group,
suggesting that laparoscopy is feasible even in case of high BMI.
Most of the studies comparing open to laparoscopic DP found no
difference in terms of complications between the two techniques
[21,22]. Sulpice et al. found no difference in the overall complication
rate between open and laparoscopy DP for adenocarcinoma, but
decreased pulmonary morbidity [20]. In the present study, there
was no difference in complications overall and if subdivided be-
tween minor and major. Moreover, there were no differences be-
tween medical and surgical complications. The pulmonary
morbidity was also similar. This shows that laparoscopy is safe
regarding short-term outcomes which is in line with the current
evidence of the literature [10]. Similarly, a review on laparoscopic
surgery published in 2016 concluded that laparoscopic DP can be
safely performed in high-volume centers, but that randomized
controlled trials still have to conﬁrm the effectiveness of the pro-
cedure [23]. A large propensity score-matching comparative study
from Japan even showed that morbidity was diminished with
laparoscopic DP along with intraoperative transfusion, and LoS
[24]. Only the operative time was longer.
An important point regarding oncologic resections is that
laparoscopic DP had the same R0 rate and the same number of
harvested lymph nodes as open DP. This suggests that laparoscopic
PD is effective for oncologic resection. This has been corroborated
by several studies [8,21,22,25,26]. The R0 rates found in this study
(15/22 and 8/10) and the median harvested lymph nodes (16 and
14) are well in line with other previously published data. On the
contrary, long-term outcomes for tumor resection are scarcer in the
literature and further need to be analyzed in studies with longer
follow-ups. A recent European survey showed that 31% of the
interrogated pancreatic surgeons still considered that laparoscopic
DP was inferior to open DP for oncologic resections [27].
As mentioned in the methods, an ERAS protocol for pancreas
surgery was implemented in 2012 in our department [16]. Even
though laparoscopy is not per se part of the pathway, minimally
invasive surgery is more and more often used in the context of
ERAS. The results of our study (diminution of LoS and intermediate
care stay) conﬁrm that laparoscopy allows having quicker recovery,
so laparoscopy complements well an ERAS pathway.
Several limitations of this study need to be acknowledged. First,
the retrospective nature of the study can bring some biases related
to the chart reviews and the potential missing data. Moreover, a
retrospective evaluation can ﬁnd a difference of characteristics
between the two study groups. The main characteristics were
however similar in both groups as illustrated in Table 1. Secondly,
the number of laparoscopic cases was quite small, and thus, inter-
pretation of the data should be done with caution. Nevertheless,
this study compares two similar groups in a single institution.
Finally, laparoscopy was performed more frequently in the recent
years. This could induce a temporal bias that needs to be taken into
consideration in the analysis.
In summary, laparoscopic DP is as safe as open DP, and post-
operative complications were similar. Laparoscopic DP allowed a
quicker return to the normal ward and shorter LoS. Minimally
invasive DP should therefore be offered whenever technically
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